Respiri Limited (RSH.AX)

AUD 0.04

(2.86%)

Long Term Debt Summary of Respiri Limited

Respiri Limited's latest annual long term debt in 2024 was - AUD , down 0.0% from previous year.
Respiri Limited's latest quarterly long term debt in 2024 FY was - AUD , down -100.0% from previous quarter.
Respiri Limited reported annual long term debt of 116.39 Thousand AUD in 2023, down 0.0% from previous year.
Respiri Limited reported annual long term debt of - AUD in 2022, down -100.0% from previous year.
Respiri Limited reported quarterly long term debt of 116.39 Thousand AUD for 2024 Q2, down 0.0% from previous quarter.
Respiri Limited reported quarterly long term debt of - AUD for 2024 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Respiri Limited (2024 - 1997)

Historical Annual Long Term Debt of Respiri Limited (2024 - 1997)

Year	Long Term Debt	Long Term Debt Growth
2024	- AUD	0.0%
2023	116.39 Thousand AUD	0.0%
2022	- AUD	-100.0%
2021	70.66 Thousand AUD	-44.81%
2020	128.04 Thousand AUD	0.0%
2019	- AUD	0.0%
2018	- AUD	0.0%
2017	- AUD	0.0%
2016	- AUD	0.0%
2015	- AUD	0.0%
2014	- AUD	0.0%
2013	- AUD	0.0%
2012	- AUD	0.0%
2011	- AUD	0.0%
2010	- AUD	0.0%
2009	- AUD	0.0%
2008	- AUD	0.0%
2007	- AUD	0.0%
2006	- AUD	0.0%
2005	- AUD	0.0%
2004	- AUD	0.0%
2003	- AUD	0.0%
2002	- AUD	-100.0%
2001	16 Thousand AUD	-23.81%
2000	21 Thousand AUD	-30.36%
1999	30.15 Thousand AUD	0.0%
1998	- AUD	0.0%
1997	- AUD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q4	- AUD	0.0%
2024 Q2	116.39 Thousand AUD	0.0%
2024 FY	- AUD	-100.0%
2023 FY	116.39 Thousand AUD	0.0%
2023 Q2	- AUD	0.0%
2023 Q4	116.39 Thousand AUD	0.0%
2022 Q2	32.39 Thousand AUD	0.0%
2022 Q4	- AUD	0.0%
2022 FY	- AUD	-100.0%
2021 FY	70.66 Thousand AUD	-44.81%
2021 Q2	144.11 Thousand AUD	0.0%
2021 Q4	70.66 Thousand AUD	0.0%
2020 FY	128.04 Thousand AUD	0.0%
2020 Q4	128.04 Thousand AUD	0.0%
2020 Q2	- AUD	0.0%
2019 Q4	- AUD	0.0%
2019 FY	- AUD	0.0%
2019 Q2	- AUD	0.0%
2018 Q4	- AUD	0.0%
2018 Q2	- AUD	0.0%
2018 FY	- AUD	0.0%
2017 Q2	- AUD	0.0%
2017 Q4	- AUD	0.0%
2017 FY	- AUD	0.0%
2016 FY	- AUD	0.0%
2016 Q2	- AUD	0.0%
2016 Q4	- AUD	0.0%
2015 Q2	- AUD	0.0%
2015 FY	- AUD	0.0%
2015 Q4	- AUD	0.0%
2014 Q4	- AUD	0.0%
2014 Q2	- AUD	0.0%
2014 FY	- AUD	0.0%
2013 Q4	- AUD	0.0%
2013 FY	- AUD	0.0%
2013 Q1	- AUD	0.0%
2013 Q2	- AUD	0.0%
2013 Q3	- AUD	0.0%
2012 Q4	- AUD	0.0%
2012 FY	- AUD	0.0%
2011 FY	- AUD	0.0%
2011 Q4	- AUD	0.0%
2010 FY	- AUD	0.0%
2010 Q4	- AUD	0.0%
2009 FY	- AUD	0.0%
2009 Q4	- AUD	0.0%
2008 FY	- AUD	0.0%
2008 Q4	- AUD	0.0%
2007 Q4	- AUD	0.0%
2007 FY	- AUD	0.0%
2006 Q4	- AUD	0.0%
2006 FY	- AUD	0.0%
2005 FY	- AUD	0.0%
2005 Q4	- AUD	0.0%
2004 Q4	- AUD	0.0%
2004 FY	- AUD	0.0%
2003 FY	- AUD	0.0%
2003 Q4	- AUD	0.0%
2002 FY	- AUD	-100.0%
2002 Q4	- AUD	0.0%
2001 Q4	16.83 Thousand AUD	0.0%
2001 FY	16 Thousand AUD	-23.81%
2000 FY	21 Thousand AUD	-30.36%
1999 FY	30.15 Thousand AUD	0.0%
1998 FY	- AUD	0.0%
1997 FY	- AUD	0.0%

Peer Long Term Debt Comparison of Respiri Limited

Name	Long Term Debt	Long Term Debt Difference
4DMedical Limited	4.17 Million AUD	100.0%
Adherium Limited	- AUD	NaN%
Aroa Biosurgery Limited	5.89 Million AUD	100.0%
Atomo Diagnostics Limited	- AUD	NaN%
Anteris Technologies Ltd	1.52 Million AUD	100.0%
Control Bionics Limited	336.16 Thousand AUD	100.0%
CardieX Limited	- AUD	NaN%
Compumedics Limited	- AUD	NaN%
Cochlear Limited	202.1 Million AUD	100.0%
CleanSpace Holdings Limited	2.76 Million AUD	100.0%
Cyclopharm Limited	4.01 Million AUD	100.0%
EMVision Medical Devices Ltd	1.76 Million AUD	100.0%
Nova Eye Medical Limited	- AUD	NaN%
HeraMED Limited	- AUD	NaN%
Imricor Medical Systems, Inc.	12.43 Million AUD	100.0%
ImpediMed Limited	810 Thousand AUD	100.0%
InhaleRx Limited	- AUD	NaN%
LBT Innovations Limited	1.74 Million AUD	100.0%
Micro-X Limited	65 Thousand AUD	100.0%
Neurotech International Limited	- AUD	NaN%
OncoSil Medical Limited	- AUD	NaN%
PolyNovo Limited	742 Thousand AUD	100.0%
SomnoMed Limited	709.07 Thousand AUD	100.0%
Universal Biosensors, Inc.	3.22 Million AUD	100.0%
Uscom Limited	- AUD	NaN%
Visioneering Technologies, Inc.	- AUD	NaN%